Loading...
Prevention of breast cancer skeletal metastases with parathyroid hormone
Advanced breast cancer is frequently associated with skeletal metastases and accelerated bone loss. Recombinant parathyroid hormone [teriparatide, PTH(1-34)] is the first anabolic agent approved in the US for treatment of osteoporosis. While signaling through the PTH receptor in the osteoblast linea...
Na minha lista:
| Udgivet i: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5621896/ https://ncbi.nlm.nih.gov/pubmed/28878134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.90874 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|